| Dr Mary Rochelle Swiggum, MD | |
|
2855 Campus Dr, Plymouth, MN 55441-2649 | |
| (763) 577-7160 | |
| Not Available |
| Full Name | Dr Mary Rochelle Swiggum |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 2855 Campus Dr, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366971988 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 67189 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healtheast St John's Hospital | Maplewood, MN | Hospital |
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Care Consultants Pa | 5496640161 | 75 |
News Archive
Colorectal cancer is one of the major causes of cancer death in the developed countries. Accumulated evidences indicate that lipid metabolism, especially the one in the arachidonic acid -pathway, appears to play a critical role in the development of CRC.
Mayo Clinic researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication these markers may help as a diagnostic tool for psychiatrists treating mood disorders.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.
› Verified 6 days ago
| Entity Name | Emergency Care Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669422788 PECOS PAC ID: 5496640161 Enrollment ID: O20040220000380 |
News Archive
Colorectal cancer is one of the major causes of cancer death in the developed countries. Accumulated evidences indicate that lipid metabolism, especially the one in the arachidonic acid -pathway, appears to play a critical role in the development of CRC.
Mayo Clinic researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication these markers may help as a diagnostic tool for psychiatrists treating mood disorders.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.
› Verified 6 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Colorectal cancer is one of the major causes of cancer death in the developed countries. Accumulated evidences indicate that lipid metabolism, especially the one in the arachidonic acid -pathway, appears to play a critical role in the development of CRC.
Mayo Clinic researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication these markers may help as a diagnostic tool for psychiatrists treating mood disorders.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Rochelle Swiggum, MD 2829 University Ave Se Ste 730, Minneapolis, MN 55414-3279 Ph: () - | Dr Mary Rochelle Swiggum, MD 2855 Campus Dr, Plymouth, MN 55441-2649 Ph: (763) 577-7160 |
News Archive
Colorectal cancer is one of the major causes of cancer death in the developed countries. Accumulated evidences indicate that lipid metabolism, especially the one in the arachidonic acid -pathway, appears to play a critical role in the development of CRC.
Mayo Clinic researchers have discovered a series of proteins that could be diagnostic markers to identify bipolar I disorder. If this discovery sample can be validated through replication these markers may help as a diagnostic tool for psychiatrists treating mood disorders.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in Dallas, Texas, researchers will report that early transplantation of human placenta-derived mesenchymal stem cells into the lateral ventricles of neonatal rats with birth-related brain damage is possible, and that the donor cells can survive and migrate in the recipient's brain.
› Verified 6 days ago
Jessica Yee, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7160 Fax: 763-577-7074 | |
Leah Vivian Patullo, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7160 Fax: 763-577-7074 | |
Christopher M Callahan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 25, Plymouth, MN 55447 Phone: 952-763-5553 | |
Elga Ottlilia Tinger, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14700 28th Ave N, Suite 25, Plymouth, MN 55447 Phone: 763-450-5553 | |
Matthew Moldan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14700 28th Ave N Ste 20, Plymouth, MN 55447 Phone: 763-559-3779 Fax: 763-450-3986 | |
Dr. Diliana Stoimenova Mittelsteadt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7160 Fax: 763-577-7074 |